Paul Bohn of Notre Dame to Speak at Bioanalytical Sensors Meeting, May 22-23, 2014, Cambridge, MA

Cambridge, MA (PressExposure) March 28, 2014 -- Paul W. Bohn, Arthur J Schmitt Professor of Chemical & Biomolecular Engineering, University of Notre Dame, to give a presentation titled "Tight Coupling of Chemical Sensing and Reactivity in Nanofluidic Architectures" at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.

Paul Bohn received his Ph.D. in Chemistry from the University of Wisconsin-Madison. He subsequently joined the faculty at the University of Illinois at Urbana-Champaign, where he served in numerous roles, including Head of the Chemistry Department, Director of the School of Chemical Sciences, and the Interim Vice Chancellor for Research. In 2006, he became the Arthur J. Schmitt Professor of Chemical & Biomolecular Engineering and Professor of Chemistry and Biochemistry at the University of Notre Dame and serves as the Director of the Advanced Diagnostics and Therapeutics Initiative, which fosters research creating tools to combat disease, promote health, and safeguard the environment.

Dr. Bohn has over 225 publications in the fields of analytical chemistry, materials science, and chemical engineering; has served as Editor for the Americas (2007-2009) and Chair of the Editoral Board (2010-2013) for Analyst; and sits on numerous editorial and scientific boards. In addition to being a Fellow of the American Association for the Advancement of Science (1998) and the Royal Society of Chemistry (UK, 2008), he has received several awards including the ACS Award in Spectrochemical Analysis (1997), the Bomem-Michelson Award from the Coblentz Society (2005), and the Theophilus Redwood Award of the Royal Society of Chemistry (2010). His research interests include integrated microfluidic and nanofluidic chemical measurement strategies for personal monitoring, chemical and biochemical sensing in mass-limited samples, and molecular approaches to nanotechnology.

This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Single Cell Analysis field. A balance of both academic and industry experts will facilitate discussion on the following areas:

I. Advances in Sensor Development
II. Clinical Applications of Bioanalytical Sensors
III. Nanopores & Nanochannels
IV. Bio-Electrochemical Sensing
V. Single Molecule Sensing

This conference is also part of the 2014 Drug Discovery Summit, which consists of the following co-located conferences:

1) Single Cell Analysis
2) GPCR Structure, Function, and Drug Discovery
3) Metabolomics: Advances & Applications in Human Disease
4) Bioanalytical Sensors

For more information, please visit

About GTC

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

GTC (Global Technology Community), LLC, is a privately held company founded in 2002.

Press Release Source:

Press Release Submitted On: March 28, 2014 at 3:21 am
This article has been viewed 48754 time(s).